Tesamorelin: Boost Growth Hormone and Reduce Belly Fat with Dragon Pharmaceuticals

Tesamorelin

Tesamorelin 5 mg by Dragon Pharma contains Tesamorelin, a synthetic GHRH peptide that stimulates natural growth hormone (GH) release. Each 5 mg vial of lyophilized powder is designed for bodybuilders seeking visceral fat reduction, muscle growth, and enhanced recovery. With a half-life of approximately 10–20 minutes, Tesamorelin delivers pulsatile GH release for a leaner, stronger physique.

What It Is

Tesamorelin is a 44-amino-acid peptide analog of GHRH, FDA-approved (as Egrifta) for reducing visceral fat in HIV-associated lipodystrophy. In bodybuilding, it's used off-label to boost GH and insulin-like growth factor-1 (IGF-1) levels, promoting fat loss (especially abdominal fat), muscle growth, and recovery. Unlike exogenous GH, Tesamorelin stimulates natural GH production, reducing risks of suppression and offering a safer alternative.

How It Works

Tesamorelin binds to GHRH receptors in the pituitary gland, triggering the release of growth hormone, which elevates IGF-1 levels. This enhances protein synthesis, fat oxidation (particularly visceral fat), and muscle repair. It's especially effective for reducing abdominal fat, improving body composition, and supporting joint health. Its short half-life ensures pulsatile GH release, mimicking natural patterns. Detection times are minimal due to its peptide nature.

Benefits

• Visceral Fat Loss: Reduces abdominal fat by up to 20% in 12–26 weeks.
• Muscle Growth: Promotes lean muscle gains (3–6 lbs in 8–12 weeks).
• Enhanced Recovery: Speeds up muscle and tissue repair.
• Joint Support: Strengthens connective tissues, reducing injury risk.
• Metabolic Health: Improves insulin sensitivity and lipid profiles.

Who It's For

Tesamorelin is ideal for male and female bodybuilders aged 21–40 seeking fat loss, muscle growth, and recovery in cutting or recomp cycles. It's suitable for intermediate to advanced users, particularly those targeting visceral fat reduction. Not for: Individuals under 21, those with pituitary tumors, or those not under medical supervision. Blood work to monitor GH, IGF-1, and glucose is recommended.

How to Use

Dosage: Typical dosage is 1–2 mg/day, administered as a single subcutaneous injection (e.g., 1000–2000 mcg). Start at 1 mg/day to assess tolerance. Women may use similar doses under medical supervision.

Administration: Reconstitute the 5 mg vial with 1–2 ml bacteriostatic water. Draw 0.2–0.4 ml (1–2 mg) into a 0.5-inch insulin syringe (27–30G) and inject subcutaneously (e.g., abdomen, thigh). Administer at night to align with natural GH pulses or post-workout. Cycles typically last 8–12 weeks, with no mandatory break as it's non-suppressive.

Results Timeline: Fat loss and recovery improvements within 2–4 weeks, with significant visceral fat reduction and muscle gains by 8–12 weeks when paired with a calorie-controlled diet and training.

Stacking Suggestions

Tesamorelin is versatile for stacking:

• Fat Loss Stack: Combine with Cardarine (10–20 mg/day) for enhanced fat burning and endurance.
• Growth Stack: Pair with CJC-1295/Ipamorelin (100–300 mcg/day each) for amplified GH release.
• Support: Use with BPC-157 (250–500 mcg/day) for synergistic tissue repair.

Side Effects

Tesamorelin is generally well-tolerated but may cause:

• Injection Site Reactions: Redness, swelling, or itching; rotate sites.
• Metabolic: Mild insulin resistance or glucose elevation; monitor blood sugar.
• Other: Joint pain, muscle aches, or headaches (10–15% of users).
• Hormonal: No testosterone suppression, as it's non-androgenic.

Tesamorelin is not hepatotoxic. Regular blood work to monitor GH, IGF-1, and glucose is advised.

Post Cycle Therapy (PCT)

Tesamorelin does not suppress testosterone or hormones, so PCT is not required. If stacked with anabolic steroids, use Clomid (50 mg/day) and Nolvadex (20–40 mg/day) for 4–6 weeks. Tesamorelin can be continued during PCT to support fat loss and recovery.